For the Inventor, By the Inventor

Enter assignee name

Labruguière, France

Neurolixis

USPTO Granted Patents = 3

EPO Patents = 2

Forward Citations = 3

Loading Chart...

Loading Chart...

8 inventors (with patents filed for the assignee):

Adrian Newman-Tancredi (3 out of 4 patents)

Mark Andrew Varney (3 out of 6 patents)

Anna Wesolowska (1 out of 1 patent)

4. Magdalena Jastrzebska-Wiesek (1 out of 1 patent)

5. Adam Bucki (1 out of 6 patents)

6. Joanna Sniecikowska (1 out of 4 patents)

7. Khaleelurrahman Abdulrazak (1 out of 1 patent)

8. Xin Tao (1 out of 1 patent)

3 patents: Sort by Forward Citations

1. 11974992 - Use of serotonin 5-HT1A receptor agonists to treat diseases associated with sudden unexpected death in epilepsy (2024-05-07),

2. 11191758 - Use of selective serotonin 5-HTreceptor agonists for treating side-effects of VMAT inhibitors (2021-12-07),

3. 10562853 - Compounds for treating disorders sensitive to serotoninergic regulation controlled by the 5-HT1A receptors (2020-02-18),

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

3 Patents

#1 in Labruguière

#4,029 in France

Labruguière, France

Neurolixis

Forward Citations = 3

8 inventors:

Adrian Newman-Tancredi (3 out of 4 patents)

Mark Andrew Varney (3 out of 6 patents)

Anna Wesolowska (1 out of 1 patent)

4. Magdalena Jastrzebska-Wiesek (1 out of 1 patent)

5. Adam Bucki (1 out of 6 patents)

Please report any incorrect information to [email protected]

Loading…